Rachel Davis

Rachel Davis, MD is Associate Professor of Psychiatry and Neurosurgery, Vice Chair for Clinical Affairs and Strategy, Medical Director of Student/Resident Mental Health, and Medical Director of the OCD Program at the University of Colorado Anschutz Medical Campus. She is Service Director for the Department of Psychiatry Psychiatric Neuromodulation and Advanced Therapeutics Service, and she specializes in Deep Brain Stimulation (DBS) for refractory, severe OCD.  Dr. Davis completed her undergraduate degree, medical school, and psychiatry residency at the University of Colorado and has been on faculty at the University of Colorado Anschutz for the past 13 years.  She is currently a Principal Investigator on an NIH BRAIN initiative studying the ethics of DBS in Schizophrenia.  

Joan A. Camprodon

Dr. Joan Camprodon is Chief of the Division of Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, and Associate Professor of Psychiatry at Harvard Medical School. Clinically, he is the founding Director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the Departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in psychiatry and behavioral neurology & neuropsychiatry. Scientifically, he directs the Laboratory for Neuropsychiatry and Neuromodulation and serves in the executive committee of the MGH Interdisciplinary Brain Center (IBC). His research uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. Critical efforts are geared towards applying the paradigms and methods of human systems neuroscience to develop high-impact clinical tools, identify targets for therapeutic action and design individualized image-guided neuromodulation treatments.